Honey vs salbutamol
Day 3 · acute cough in children
1 finding from 1 review
- no estimate extracted3 participantsGRADE not reported
Findings
What do systematic reviews say?
3,703 questions · 3,824 findings · 858 reviews
No studies found 573 · 15%GRADE not reported 383 · 10%Very low 993 · 26%Low 1,062 · 27.8%Moderate 614 · 16.1%High 199 · 5.2%
Pharmacological detoxification treatment vs other pharmacological detoxification treatment
Withdrawal symptoms · management of opium withdrawal
4 findings from 1 review
- no estimate extracted72 participantsVery low
- no estimate extracted1 study · 40 participantsLow
- no estimate extracted60 participantsVery low
Show 1 more finding
- no estimate extracted34 participantsVery low
Single dose primaquine at 0.2 to 0.25 mg/kg vs no primaquine, with artemisinin partner,
Participants infectious at day 8 · adults and children with malaria being treated with artemisinin combination treatment
Single dose primaquine at 0.2 to 0.25 mg/kg may leads to lower participants infectious at day 3‐4 compared with no primaquine, with artemisinin partner, (low certainty).
2 findings from 1 review
- Primaquine or other 8‐aminoquinolines for reducing Plasmodium falciparum transmission 2018 · Cochrane Headline outcomes onlyRR 0.12 [0.02, 0.88]3 studies · 105 participantsLow
- Primaquine or other 8‐aminoquinolines for reducing Plasmodium falciparum transmission 2018 · Cochrane Headline outcomes onlyRR 0.34 [0.07, 1.58]4 studies · 243 participantsLow
Single dose primaquine at 0.75 mg/kg vs no primaquine, with artemisinin partner,
Participants infectious at day 8 · adults and children with malaria being treated with artemisinin combination treatment
Single dose primaquine at 0.75 mg/kg showed no clear difference in participants infectious at day 3‐4 compared with no primaquine, with artemisinin partner, (low certainty).
2 findings from 1 review
- Primaquine or other 8‐aminoquinolines for reducing Plasmodium falciparum transmission 2018 · Cochrane Headline outcomes onlyRR 0.2 [0.02, 1.68]1 study · 101 participantsLow
- Primaquine or other 8‐aminoquinolines for reducing Plasmodium falciparum transmission 2018 · Cochrane Headline outcomes onlyRR 0.18 [0.02, 1.41]2 studies · 181 participantsLow
Single dose primaquine at 0.75 mg/kg vs no primaquine, with artemisinin partner,
Participants with gametocytes at day 3‐4, by PCR · adults and children with malaria being treated with artemisinin combination treatment
Single dose primaquine at 0.75 mg/kg showed no clear difference in participants with gametocytes at day 3‐4, by PCR compared with no primaquine, with artemisinin partner, (low certainty).
1 finding from 1 review
- Primaquine or other 8‐aminoquinolines for reducing Plasmodium falciparum transmission 2018 · Cochrane Headline outcomes onlyRR 0.92 [0.75, 1.13]2 studies · 290 participantsLow
Single dose primaquine at 0.2 to 0.25 mg/kg vs no primaquine, with artemisinin partner,
Participants with gametocytes at day 3‐4, by PCR · adults and children with malaria being treated with artemisinin combination treatment
Single dose primaquine at 0.2 to 0.25 mg/kg showed no clear difference in participants with gametocytes at day 3 to 4 by PCR compared with no primaquine, with artemisinin partner, (moderate certainty).
1 finding from 1 review
- Primaquine or other 8‐aminoquinolines for reducing Plasmodium falciparum transmission 2018 · Cochrane Headline outcomes onlyRR 1.02 [0.87, 1.21]3 studies · 414 participantsModerate
Single dose primaquine at 0.4 to 0.5 mg/kg vs no primaquine, with artemisinin partner,
Participants infectious at day 8 · adults and children with malaria being treated with artemisinin combination treatment
Single dose primaquine at 0.4 to 0.5 mg/kg may leads to lower participants infectious at day 3‐4 compared with no primaquine, with artemisinin partner, (low certainty).
2 findings from 1 review
- Primaquine or other 8‐aminoquinolines for reducing Plasmodium falciparum transmission 2018 · Cochrane Headline outcomes onlyRR 0.13 [0.02, 0.94]3 studies · 109 participantsLow
- Primaquine or other 8‐aminoquinolines for reducing Plasmodium falciparum transmission 2018 · Cochrane Headline outcomes onlyRR 0.33 [0.07, 1.57]4 studies · 246 participantsLow
Single dose primaquine at 0.4 to 0.5 mg/kg vs no primaquine, with artemisinin partner,
Participants with gametocytes at day 3‐4, by PCR · adults and children with malaria being treated with artemisinin combination treatment
Single dose primaquine at 0.4 to 0.5 mg/kg showed no clear difference in participants with gametocytes at day 3‐4, by PCR compared with no primaquine, with artemisinin partner, (moderate certainty).
1 finding from 1 review
- Primaquine or other 8‐aminoquinolines for reducing Plasmodium falciparum transmission 2018 · Cochrane Headline outcomes onlyRR 1.09 [0.93, 1.28]3 studies · 418 participantsModerate
Smectite vs control
Clinical resolution · acute infectious diarrhoea in children
Smectite may leads to higher clinical resolution at day 3 compared with control (low certainty).
1 finding from 1 review
- RR 2.1 [1.3, 3.39]5 studies · 312 participantsLow
Information or education intervention as part of a complex intervention vs complex intervention without information or education
Patient or carer satisfaction with information provided CCFNI (between day 3 and day 5); scale from 14 to 56 Lower scores indicate increased satisfaction. FS‐ICU 24 (90 days after randomisation); scale from 0 to 100 Lower scores indicate less sati... · adult ICU patients and their carers
1 finding from 1 review
- Information or education interventions for adult intensive care unit (ICU) patients and their carers 2018 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 487 participantsVery low
Coblation vs Different surgical technique (any)
Pain postoperative day 3 № of participants: 401 (5 studies) · patients requiring tonsillectomy (any diagnosis)
1 finding from 1 review
- no estimate extractedStudies not reportedVery low
Intervention not reported
Serum creatinine: day 3 · patients undergoing a surgical intervention that induces kidney injury
1 finding from 1 review
- Ischaemic preconditioning for the reduction of renal ischaemia reperfusion injury 2017 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedHigh
Intravenous fluid supplementation vs no fluid supplementation
Frequency of breastfeeding per day · newborn infants with unconjugated hyperbilirubinaemia undergoing phototherapy
1 finding from 1 review
- Fluid supplementation for neonatal unconjugated hyperbilirubinaemia 2017 · Cochrane Headline outcomes onlyno estimate extracted1 study · 60 participantsModerate
Non‐exclusive breastfeeding (water or glucose water) vs exclusive breastfeeding
Weight loss (%) day 3 (percentage of birthweight) · healthy breastfeeding full‐term infants
1 finding from 1 review
- Early additional food and fluids for healthy breastfed full‐term infants 2016 · Cochrane Headline outcomes onlyno estimate extracted1 study · 47 participantsVery low
Intensive vs less intensive continuous renal replacement therapy (CRRT)
Mortality at day 30 · AKI
Intensive showed no clear difference in mortality at day 30 compared with less intensive continuous renal replacement therapy (CRRT) (low certainty).
1 finding from 1 review
- Intensity of continuous renal replacement therapy for acute kidney injury 2016 · Cochrane Headline outcomes onlyRR 0.88 [0.81, 1.1]5 studies · 2402 participantsLow
Montelukast vs placebo
Clinical severity score (day 3) · children with acute bronchiolitis
1 finding from 1 review
- Leukotriene inhibitors for bronchiolitis in infants and young children 2015 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 132 participantsLow
PEEP vs zero end‐expiratory pressure (ZEEP) during mechanical ventilation
Oxygen efficiency (PaO2/FiO2) day 3 postoperative · adult participants given general anaesthesia
1 finding from 1 review
- Positive end‐expiratory pressure (PEEP) during anaesthesia for prevention of mortality and postoperative pulmonary… 2014 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 80 participantsVery low
Intervention not reported
Adverse events (day 7 to day 30 post‐donation) · Haemopoietic stem cell donors
1 finding from 1 review
- Bone marrow harvest versus peripheral stem cell collection for haemopoietic stem cell donation in healthy donors 2009 · Cochrane Headline outcomes onlyno estimate extracted6 studies · 656 participantsLow
Intervention not reported
Pain subsequent to donation ("after collection" ‐ day 30 post‐donation) · Haemopoietic stem cell donors
1 finding from 1 review
- Bone marrow harvest versus peripheral stem cell collection for haemopoietic stem cell donation in healthy donors 2009 · Cochrane Headline outcomes onlyno estimate extracted6 studies · 656 participantsLow
Prednisone vs prednisone and plasma exchange (Gajdos 1983)
Score (MMS) day 30
1 finding from 1 review
- no estimate extracted1 study · 14 participantsLow